Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 11 May 2024 22:35:01 +0200Mon, 13 Nov 2023 13:42:00 +0100Opinion/decision on a Paediatric investigation plan (PIP): Kyntheum, brodalumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0490/2022https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001089-pip02-13-m03Opinion/decision on a Paediatric investigation plan (PIP): Kyntheum, brodalumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0490/2022https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001089-pip02-13-m03Mon, 13 Nov 2023 13:42:00 +0100Human medicine